| 注册
首页|期刊导航|中国医学创新|血清中25-OH-D、FGF23因子对骨质疏松患者糖皮质激素治疗疗效的评估价值分析

血清中25-OH-D、FGF23因子对骨质疏松患者糖皮质激素治疗疗效的评估价值分析

潘英 陈东 李娜

中国医学创新2016,Vol.13Issue(18):26-29,4.
中国医学创新2016,Vol.13Issue(18):26-29,4.DOI:10.3969/j.issn.1674-4985.2016.18.008

血清中25-OH-D、FGF23因子对骨质疏松患者糖皮质激素治疗疗效的评估价值分析

Evaluation of Value for Curative Effect of Serum 25-OH-D,FGF23 Factors Glucocorticoid Therapy in Patients with Osteoporosis

潘英 1陈东 1李娜1

作者信息

  • 1. 广东省深圳市宝安区中心医院 广东 深圳 518102
  • 折叠

摘要

Abstract

Objective:To discuss the evaluation of value for curative effect of serum 25-OH-D,FGF23 factors glucocorticoid therapy in patients with osteoporosis.Method:A total of 120 patients with osteoporosis were selected for retrospective analysis from August 2014 to June 2015 glucocorticoid treatment, therapy for half a year, before treatment adopt bone mineral density,bone mineral density detector to detect the bone mineral density T value in -1.0- -2.5 s,according to their bone mineral density all patients were divided into group A(T=+2.5--1.0 s),group B(T=-1.0--2.5 s) and group C(T<-2.5 s),the contrast between different groups before and after drug serum 25-OH-D,FGF23 factor level difference,ROC curve analysis was used to evaluate the accuracy of the two factors of patients after treatment efficacy.Result:After treatment serum 25-OH-D,FGF23 factors levels of group A,B were significantly higher than those of before treatment,the difference was statistically significant (P<0.05),patients in group C before and after treatment serum 25-OH-D,FGF23 factor levels had no significant difference(P>0.05).In the respect of after treatment serum 25-OH-D,FGF23 factor levels,group A>group B>group C(P<0.05).According to the results of ROC curve analysis,25-OH-D evaluated after the assessment of osteoporosis treatment,the curative effect was 71.34%,the sensitivity was 83.45%,the accuracy effect was 86.71%,FGF23 evaluated after the assessment of osteoporosis treatment,the curative effect was 79.64%,the sensitivity was 88.57%,the accuracy effect was 91.22%. Conclusion:Serum 25-OH-D,FGF23 factors are closely related to the condition of patients with osteoporosis,in the early diagnosis of evaluation curative effect after treatment has better specific degrees,sensitivity,accuracy,it’s better to guide clinical treatment,it’s worth of further clinical promotion.

关键词

25-OH-D/FGF23/骨质疏松/糖皮质激素/疗效

Key words

25-OH-D/FGF23/Osteoporosis/Glucocorticoids/Curative effect

引用本文复制引用

潘英,陈东,李娜..血清中25-OH-D、FGF23因子对骨质疏松患者糖皮质激素治疗疗效的评估价值分析[J].中国医学创新,2016,13(18):26-29,4.

基金项目

深圳市宝安区社会公益资助项目 ()

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文